{"id":4028,"date":"2023-04-17T20:31:13","date_gmt":"2023-04-17T20:31:13","guid":{"rendered":"https:\/\/founderlodge.com\/latest-news\/?p=4028"},"modified":"2023-04-17T20:31:14","modified_gmt":"2023-04-17T20:31:14","slug":"aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases","status":"publish","type":"post","link":"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/","title":{"rendered":"Aer Therapeutics Raises $36M in Series A Funding for Lung Diseases"},"content":{"rendered":"
\n
\"\"<\/figure><\/div>\n\n\n

Aer Therapeutics<\/a>, a clinical-stage biopharmaceutical company based in San Francisco, California, has raised $36 million in a Series A round. The funding was led by Hatteras Venture Partners<\/a>, with participation from OrbiMed<\/a> and Canaan<\/a>.<\/p>\n\n\n\n

Aer Therapeutics is developing a novel inhaled approach to treat lung diseases characterized by excess mucus and mucus plugs, such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, and asthma. The company’s lead therapeutic candidate, AER-01, has shown promising preliminary safety and efficacy profiles in clinical trials, thanks to the efforts of a research consortium led by Dr. John Fahy’s airway biology lab at the University of California San Francisco (UCSF) in collaboration with Dr. Stefan Oscarson’s glycochemistry lab at University College Dublin and Dr. Anne Marie Healy’s pharmaceutics lab at Trinity College Dublin.<\/p>\n\n\n\n

\"The<\/figure>\n\n\n\n

The $36 million Series A funding will enable Aer Therapeutics to further develop and advance AER-01 and its inhaled approach to treating lung diseases, which has the potential to transform the lives of millions of people worldwide who suffer from these debilitating conditions. <\/p>\n\n\n\n

\"The<\/figure>\n\n\n\n

With the backing of Hatteras Venture Partners, OrbiMed, and Canaan, Aer Therapeutics is well-positioned to bring its innovative treatments to market and make a significant impact in the field of respiratory medicine. Visit us for more information about their latest funding round: https:\/\/founderlodge.com\/round\/Aer-Therapeutics-Inc-raises-36000000-Series-A-2023-04-17-John-Fahy-MTIyMTg<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Aer Therapeutics, a clinical-stage biopharmaceutical company based in San Francisco, California, has raised $36 million in a Series A round. The funding was led by Hatteras Venture Partners, with participation from OrbiMed and Canaan. Aer Therapeutics is developing a novel inhaled approach to treat lung diseases characterized by excess mucus and mucus plugs, such as […]<\/p>\n","protected":false},"author":3,"featured_media":4032,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":""},"categories":[2],"tags":[663,553,664,169],"yoast_head":"\nAer Therapeutics Raises $36M in Series A Funding for Lung Diseases - Founder Lodge Latest News<\/title>\n<meta name=\"description\" content=\"Aer Therapeutics, a clinical-stage biopharmaceutical company based in San Francisco, California, has raised $36 million in a Series A round. The funding\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aer Therapeutics Raises $36M in Series A Funding for Lung Diseases - Founder Lodge Latest News\" \/>\n<meta property=\"og:description\" content=\"Aer Therapeutics, a clinical-stage biopharmaceutical company based in San Francisco, California, has raised $36 million in a Series A round. The funding\" \/>\n<meta property=\"og:url\" content=\"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/\" \/>\n<meta property=\"og:site_name\" content=\"Founder Lodge Latest News\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-17T20:31:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-17T20:31:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/Screenshot-112.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1336\" \/>\n\t<meta property=\"og:image:height\" content=\"629\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Ayesha Kanwal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ayesha Kanwal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/\"},\"author\":{\"name\":\"Ayesha Kanwal\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/84b30b34a96b8f66e08acd79b29fc198\"},\"headline\":\"Aer Therapeutics Raises $36M in Series A Funding for Lung Diseases\",\"datePublished\":\"2023-04-17T20:31:13+00:00\",\"dateModified\":\"2023-04-17T20:31:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/\"},\"wordCount\":231,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"keywords\":[\"Aer Therapeutics\",\"latest funding round\",\"Lung Diseases\",\"Series B Funding\"],\"articleSection\":[\"Daily Startup Funding News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/\",\"name\":\"Aer Therapeutics Raises $36M in Series A Funding for Lung Diseases - Founder Lodge Latest News\",\"isPartOf\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\"},\"datePublished\":\"2023-04-17T20:31:13+00:00\",\"dateModified\":\"2023-04-17T20:31:14+00:00\",\"description\":\"Aer Therapeutics, a clinical-stage biopharmaceutical company based in San Francisco, California, has raised $36 million in a Series A round. The funding\",\"breadcrumb\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/founderlodge.com\/latest-news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aer Therapeutics Raises $36M in Series A Funding for Lung Diseases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#website\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"name\":\"Founder Lodge Latest News\",\"description\":\"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who's raising capital.\",\"publisher\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#organization\",\"name\":\"Founder Lodge\",\"url\":\"https:\/\/founderlodge.com\/latest-news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Founder Lodge\"},\"image\":{\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/84b30b34a96b8f66e08acd79b29fc198\",\"name\":\"Ayesha Kanwal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7657d62981ef50c7c94f042b91db49ad?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7657d62981ef50c7c94f042b91db49ad?s=96&d=mm&r=g\",\"caption\":\"Ayesha Kanwal\"},\"url\":\"https:\/\/founderlodge.com\/latest-news\/author\/aisha\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aer Therapeutics Raises $36M in Series A Funding for Lung Diseases - Founder Lodge Latest News","description":"Aer Therapeutics, a clinical-stage biopharmaceutical company based in San Francisco, California, has raised $36 million in a Series A round. The funding","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/","og_locale":"en_US","og_type":"article","og_title":"Aer Therapeutics Raises $36M in Series A Funding for Lung Diseases - Founder Lodge Latest News","og_description":"Aer Therapeutics, a clinical-stage biopharmaceutical company based in San Francisco, California, has raised $36 million in a Series A round. The funding","og_url":"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/","og_site_name":"Founder Lodge Latest News","article_published_time":"2023-04-17T20:31:13+00:00","article_modified_time":"2023-04-17T20:31:14+00:00","og_image":[{"width":1336,"height":629,"url":"https:\/\/founderlodge.com\/latest-news\/wp-content\/uploads\/2023\/04\/Screenshot-112.png","type":"image\/png"}],"author":"Ayesha Kanwal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ayesha Kanwal","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/#article","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/"},"author":{"name":"Ayesha Kanwal","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/84b30b34a96b8f66e08acd79b29fc198"},"headline":"Aer Therapeutics Raises $36M in Series A Funding for Lung Diseases","datePublished":"2023-04-17T20:31:13+00:00","dateModified":"2023-04-17T20:31:14+00:00","mainEntityOfPage":{"@id":"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/"},"wordCount":231,"commentCount":0,"publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"keywords":["Aer Therapeutics","latest funding round","Lung Diseases","Series B Funding"],"articleSection":["Daily Startup Funding News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/","url":"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/","name":"Aer Therapeutics Raises $36M in Series A Funding for Lung Diseases - Founder Lodge Latest News","isPartOf":{"@id":"https:\/\/founderlodge.com\/latest-news\/#website"},"datePublished":"2023-04-17T20:31:13+00:00","dateModified":"2023-04-17T20:31:14+00:00","description":"Aer Therapeutics, a clinical-stage biopharmaceutical company based in San Francisco, California, has raised $36 million in a Series A round. The funding","breadcrumb":{"@id":"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/founderlodge.com\/latest-news\/aer-therapeutics-raises-36m-in-series-a-funding-for-lung-diseases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/founderlodge.com\/latest-news\/"},{"@type":"ListItem","position":2,"name":"Aer Therapeutics Raises $36M in Series A Funding for Lung Diseases"}]},{"@type":"WebSite","@id":"https:\/\/founderlodge.com\/latest-news\/#website","url":"https:\/\/founderlodge.com\/latest-news\/","name":"Founder Lodge Latest News","description":"Get the latest updates on funding rounds and investment news for startups and businesses. Stay informed on capital raising trends and who's raising capital.","publisher":{"@id":"https:\/\/founderlodge.com\/latest-news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/founderlodge.com\/latest-news\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/founderlodge.com\/latest-news\/#organization","name":"Founder Lodge","url":"https:\/\/founderlodge.com\/latest-news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Founder Lodge"},"image":{"@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/84b30b34a96b8f66e08acd79b29fc198","name":"Ayesha Kanwal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/founderlodge.com\/latest-news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7657d62981ef50c7c94f042b91db49ad?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7657d62981ef50c7c94f042b91db49ad?s=96&d=mm&r=g","caption":"Ayesha Kanwal"},"url":"https:\/\/founderlodge.com\/latest-news\/author\/aisha\/"}]}},"_links":{"self":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/4028"}],"collection":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/comments?post=4028"}],"version-history":[{"count":1,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/4028\/revisions"}],"predecessor-version":[{"id":4033,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/posts\/4028\/revisions\/4033"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media\/4032"}],"wp:attachment":[{"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/media?parent=4028"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/categories?post=4028"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/founderlodge.com\/latest-news\/wp-json\/wp\/v2\/tags?post=4028"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}